Literature DB >> 16871440

Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope.

Cheryl A D'Souza1, Mario A Moscarello.   

Abstract

Charge microheterogeneity of myelin basic protein is known to affect its conformation and function. Here, the citrullinated myelin basic protein charge isomer, component-8, was shown to be more susceptible to stromelysin-1 cleavage than myelin basic protein component-1. Since levels of component-8 are increased in multiple sclerosis brain, the increased susceptibility of component-8 to proteolytic digestion may play a role in the pathogenesis of multiple sclerosis. Interestingly, component-1 isolated from multiple sclerosis patients was digested at a faster rate by stromelysin-1 than component-1 isolated from normal individuals. The reason for this difference is not clear, but likely reflects conformational differences between the two proteins as a result of post-translational modifications. Stromelysin-1 was able to cleave myelin basic protein in the presence of lipids and within the context of myelin and released several peptides including peptides containing the immunodominant epitope.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871440     DOI: 10.1007/s11064-006-9116-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

Review 1.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Matrix metalloproteinases degrade myelin basic protein.

Authors:  S Chandler; R Coates; A Gearing; J Lury; G Wells; E Bone
Journal:  Neurosci Lett       Date:  1995-12-15       Impact factor: 3.046

3.  The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein.

Authors:  D D Wood; M A Moscarello
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

Review 4.  Proteolysis and myelin breakdown: a review of recent histochemical and biochemical studies.

Authors:  J F Hallpike; C W Adams
Journal:  Histochem J       Date:  1969-11

5.  Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry.

Authors:  Cheryl A D'Souza; D Denise Wood; Yi-Min She; Mario A Moscarello
Journal:  Biochemistry       Date:  2005-09-27       Impact factor: 3.162

6.  Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.

Authors:  M L Cuzner; A N Davison; P Rudge
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

7.  Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.

Authors:  A Maeda; R A Sobel
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

8.  The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease.

Authors:  Cheryl A D'Souza; Baldwin Mak; Mario A Moscarello
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

9.  Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.

Authors:  A J Fosang; P J Neame; T E Hardingham; G Murphy; J A Hamilton
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

10.  Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

Authors:  Mark R Kotter; Wen-Wu Li; Chao Zhao; Robin J M Franklin
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

View more
  23 in total

1.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

2.  Site-specific degradation of myelin basic protein by the proteasome.

Authors:  A A Belogurov; N A Ponomarenko; V M Govorun; A G Gabibov; A V Bacheva
Journal:  Dokl Biochem Biophys       Date:  2009 Mar-Apr       Impact factor: 0.788

Review 3.  Matrix metalloproteinases - From the cleavage data to the prediction tools and beyond.

Authors:  Piotr Cieplak; Alex Y Strongin
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-03-24       Impact factor: 4.739

4.  A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.

Authors:  Albert G Remacle; Jennifer Dolkas; Mila Angert; Swathi K Hullugundi; Andrei V Chernov; R Carter W Jones; Veronica I Shubayev; Alex Y Strongin
Journal:  J Immunol Methods       Date:  2018-02-08       Impact factor: 2.303

5.  Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain.

Authors:  Weijiao Xie; Hitoshi Uchida; Jun Nagai; Mutsumi Ueda; Jerold Chun; Hiroshi Ueda
Journal:  J Neurochem       Date:  2010-05       Impact factor: 5.372

6.  Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.

Authors:  Sharmila Chattopadhyay; Robert R Myers; Julie Janes; Veronica Shubayev
Journal:  Brain Behav Immun       Date:  2006-12-26       Impact factor: 7.217

7.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

8.  Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia.

Authors:  Espen J Walker; Gary A Rosenberg
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

9.  Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.

Authors:  Abdiwahab A Musse; Zhen Li; Cameron A Ackerley; Dorothee Bienzle; Helena Lei; Roberto Poma; George Harauz; Mario A Moscarello; Fabrizio G Mastronardi
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

Review 10.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.